PMI Research Laboratories Singapore is dedicated to inhalation toxicology and respiratory science. Our expertise in large scale aerosol generation for inhalation toxicology assessments and their effects on the respiratory, cardiovascular and central nervous systems along with OECD/FDA-recognized quality system positions us as a unique "one-stop-shop" inhalation science CRO in the Asia Pacific region. Our core capabilities are end-to-end inhalation toxicology studies in rodents, in vivo pharmacology as well as animal models of disease, which are enabled via state-of-the-art infrastructure and technologies for aerosol generation, pulmonary delivery of aerosols and bioanalytical assessments. In addition, we are experts in aerosol delivery to cellular systems for in vitro toxicology assessment, preclinical drug development, standard in vivo toxicology and analytical method development and validation to support preclinical sample analysis. Studies can be conducted in compliance to Good Laboratory Practices (GLP) standards in accordance to OECD test guidelines and SEND-ready for submission to regulatory authorities. Toxicology studies can also be supplemented with systems biology approaches to gain a holistic understanding of disease pathways. We have been OECD GLP and AAALAC accredited since 2010 to provide the assurance of superior quality, data integrity and animal welfare standards.